mRNA Therapeutics Market Size, Share, Trends, Growth Outlook

mRNA Therapeutics Market is estimated to increase at a growth rate of 2.3% CAGR over the forecast period from 2024 to 2030.

The global mRNA Therapeutics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others).

An introduction to mRNA Therapeutics Market in 2024

The mRNA Therapeutics market continues to expand rapidly in 2024, fueled by groundbreaking advancements in mRNA technology platforms, the successful clinical validation of mRNA-based therapies across diverse therapeutic areas, and the increasing investment from biopharmaceutical companies and government agencies to accelerate the development and commercialization of mRNA drugs. mRNA therapeutics represent a transformative approach to drug discovery and development, offering precise and customizable treatments for a broad range of diseases, including infectious diseases, cancer, and genetic disorders, by harnessing the body's own cellular machinery to produce therapeutic proteins or induce immune responses. Market dynamics are shaped by factors such as the growing understanding of mRNA biology and delivery mechanisms, the expansion of mRNA manufacturing capacities and infrastructure, and the regulatory approvals of mRNA vaccines and therapies. Collaboration between mRNA technology pioneers, pharmaceutical companies, and regulatory authorities fosters innovation in the mRNA Therapeutics market, leading to the discovery of novel mRNA targets, the optimization of delivery systems, and the development of next-generation mRNA-based drugs with enhanced efficacy, safety, and scalability.

mRNA Therapeutics Market Trend: Advancements in mRNA Delivery Technology

One of the most prominent trends in the mRNA Therapeutics Market is the continuous advancement in mRNA delivery technology. As mRNA-based therapies gain traction in treating various diseases, including cancer and infectious diseases, there's a growing focus on improving delivery methods to enhance efficacy and safety. Innovations such as lipid nanoparticles (LNPs), polymer-based carriers, and cell-targeted delivery systems are emerging, offering more efficient and targeted delivery of mRNA therapeutics, thus driving market growth.

mRNA Therapeutics Market Driver: Increasing Investment in mRNA Research and Development

A significant driver propelling the mRNA Therapeutics Market is the escalating investment in mRNA research and development. Pharmaceutical companies, biotech firms, and academic institutions are pouring substantial resources into exploring the therapeutic potential of mRNA, driven by its ability to address unmet medical needs and its versatility in targeting a wide range of diseases. With increasing funding and collaborations, the pace of innovation in mRNA technology is accelerating, fostering the development of novel therapies and expanding the market landscape.

mRNA Therapeutics Market Opportunity: Expansion of mRNA Therapeutics into Rare Diseases

An enticing opportunity within the mRNA Therapeutics Market lies in the expansion of mRNA-based therapies into rare diseases. While mRNA therapeutics have shown promise in addressing prevalent diseases like cancer and infectious diseases, there's a growing interest in leveraging their unique mechanisms of action to target rare genetic disorders and orphan diseases. With advancements in delivery technology and growing understanding of disease biology, there's potential to develop highly targeted and personalized mRNA therapies for rare diseases, tapping into a niche market with significant unmet needs and limited treatment options.

mRNA Therapeutics Market Market Segmentation

By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

mRNA Therapeutics Market Companies

Arcturus Therapeutics
Argos Therapeutics Inc
AstraZeneca plc.
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
GSK plc.
Moderna Inc
Pfizer Inc
Sangamo Therapeutics Inc
Translate Bio Inc

Reasons to Buy the mRNA Therapeutics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the mRNA Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the mRNA Therapeutics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 mRNA Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global mRNA Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 mRNA Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 mRNA Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 mRNA Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 mRNA Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of mRNA Therapeutics Industry
4.2 Key Market Trends in mRNA Therapeutics Industry
4.3 Potential Opportunities in mRNA Therapeutics Industry
4.4 Key Challenges in mRNA Therapeutics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global mRNA Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global mRNA Therapeutics Market Outlook by Segments
7.1 mRNA Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

8 North America mRNA Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America mRNA Therapeutics Markets in 2024
8.2 North America mRNA Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America mRNA Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

9 Europe mRNA Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe mRNA Therapeutics Markets in 2024
9.2 Europe mRNA Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe mRNA Therapeutics Market Size Outlook by Segments, 2021-2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

10 Asia Pacific mRNA Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific mRNA Therapeutics Markets in 2024
10.2 Asia Pacific mRNA Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific mRNA Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

11 South America mRNA Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America mRNA Therapeutics Markets in 2024
11.2 South America mRNA Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America mRNA Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

12 Middle East and Africa mRNA Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa mRNA Therapeutics Markets in 2024
12.2 Middle East and Africa mRNA Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa mRNA Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Arcturus Therapeutics
Argos Therapeutics Inc
AstraZeneca plc.
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
GSK plc.
Moderna Inc
Pfizer Inc
Sangamo Therapeutics Inc
Translate Bio Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Vaccines
Drugs
By Application
Infectious Diseases
Rare Genetic Diseases
Respiratory Diseases
Others
By End-User
Hospitals & Clinics
Research & Others